306 related articles for article (PubMed ID: 26694880)
1. Expression of osteoclastogenic factor transcripts in osteoblast-like UMR-106 cells after exposure to FGF-23 or FGF-23 combined with parathyroid hormone.
Teerapornpuntakit J; Wongdee K; Krishnamra N; Charoenphandhu N
Cell Biol Int; 2016 Mar; 40(3):329-40. PubMed ID: 26694880
[TBL] [Abstract][Full Text] [Related]
2. Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: altered expression of collagenase, cell growth-related, and mineralization-associated genes.
Tang KT; Capparelli C; Stein JL; Stein GS; Lian JB; Huber AC; Braverman LE; DeVito WJ
J Cell Biochem; 1996 Apr; 61(1):152-66. PubMed ID: 8726364
[TBL] [Abstract][Full Text] [Related]
3. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.
Katsuyama T; Otsuka F; Terasaka T; Inagaki K; Takano-Narazaki M; Matsumoto Y; Sada KE; Makino H
Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788
[TBL] [Abstract][Full Text] [Related]
4. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.
Ishizuya T; Yokose S; Hori M; Noda T; Suda T; Yoshiki S; Yamaguchi A
J Clin Invest; 1997 Jun; 99(12):2961-70. PubMed ID: 9185520
[TBL] [Abstract][Full Text] [Related]
6. Sprouty2 is involved in the control of osteoblast proliferation and differentiation through the FGF and BMP signaling pathways.
Taketomi T; Onimura T; Yoshiga D; Muratsu D; Sanui T; Fukuda T; Kusukawa J; Nakamura S
Cell Biol Int; 2018 Sep; 42(9):1106-1114. PubMed ID: 28921936
[TBL] [Abstract][Full Text] [Related]
7. Identification of a PTH regulated gene selectively induced in vivo during PTH-mediated bone formation.
Robinson JA; Susulic V; Liu YB; Taylor C; Hardenburg J; Gironda V; Zhao W; Kharode Y; McLarney S; Bai Y; Malone DP; Murrills R; Bex F
J Cell Biochem; 2006 Aug; 98(5):1203-20. PubMed ID: 16514668
[TBL] [Abstract][Full Text] [Related]
8. The PERK-EIF2α-ATF4 signaling branch regulates osteoblast differentiation and proliferation by PTH.
Zhang K; Wang M; Li Y; Li C; Tang S; Qu X; Feng N; Wu Y
Am J Physiol Endocrinol Metab; 2019 Apr; 316(4):E590-E604. PubMed ID: 30668150
[TBL] [Abstract][Full Text] [Related]
9. Osteostatin improves the osteogenic activity of fibroblast growth factor-2 immobilized in Si-doped hydroxyapatite in osteoblastic cells.
Lozano D; Feito MJ; Portal-Núñez S; Lozano RM; Matesanz MC; Serrano MC; Vallet-Regí M; Portolés MT; Esbrit P
Acta Biomater; 2012 Jul; 8(7):2770-7. PubMed ID: 22487933
[TBL] [Abstract][Full Text] [Related]
10. The effects of prostaglandin E2, parathyroid hormone, and epidermal growth factor on mitogenesis, signaling, and primary response genes in UMR 106-01 osteoblast-like cells.
Fang MA; Kujubu DA; Hahn TJ
Endocrinology; 1992 Nov; 131(5):2113-9. PubMed ID: 1330491
[TBL] [Abstract][Full Text] [Related]
11. ClC-3 chloride channel mediates the role of parathyroid hormone [1-34] on osteogenic differentiation of osteoblasts.
Lu X; Ding Y; Niu Q; Xuan S; Yang Y; Jin Y; Wang H
PLoS One; 2017; 12(4):e0176196. PubMed ID: 28437476
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess.
Kuriwaka-Kido R; Kido S; Miyatani Y; Ito Y; Kondo T; Omatsu T; Dong B; Endo I; Miyamoto K; Matsumoto T
Endocrinology; 2013 Mar; 154(3):1156-67. PubMed ID: 23397032
[TBL] [Abstract][Full Text] [Related]
13. Actions of fibroblast growth factor-8 in bone cells in vitro.
Lin JM; Callon KE; Lin JS; Watson M; Empson V; Tong PC; Grey A; Naot D; Green CR; Reid IR; Cornish J
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E142-50. PubMed ID: 19383871
[TBL] [Abstract][Full Text] [Related]
14. BMP9 prevents induction of osteopontin in JNK-inactivated osteoblasts via Hey1-Id4 interaction.
Kusuyama J; Seong C; Nakamura T; Ohnishi T; Amir MS; Shima K; Semba I; Noguchi K; Matsuguchi T
Int J Biochem Cell Biol; 2019 Nov; 116():105614. PubMed ID: 31550547
[TBL] [Abstract][Full Text] [Related]
15. Regulation of 25-hydroxyvitamin D-1-hydroxylase and 24-hydroxylase in keratinocytes by PTH and FGF23.
Wu W; Fan H; Jiang Y; Liao L; Li L; Zhao J; Zhang H; Shrestha C; Xie Z
Exp Dermatol; 2018 Nov; 27(11):1201-1209. PubMed ID: 30066343
[TBL] [Abstract][Full Text] [Related]
16. C-type natriuretic peptide stimulates osteoblastic proliferation and collagen-X expression but suppresses fibroblast growth factor-23 expression in vitro.
Chen WX; Liu HH; Li RX; Mammadov G; Wang JJ; Liu FF; Samadli S; Wu YF; Zhang DD; Luo HH; Hu P
Pediatr Rheumatol Online J; 2020 Jun; 18(1):46. PubMed ID: 32517762
[TBL] [Abstract][Full Text] [Related]
17. Changes in the mRNA expression of osteoblast-related genes in response to beta(3)-adrenergic agonist in UMR106 cells.
Nuntapornsak A; Wongdee K; Thongbunchoo J; Krishnamra N; Charoenphandhu N
Cell Biochem Funct; 2010 Jan; 28(1):45-51. PubMed ID: 19827007
[TBL] [Abstract][Full Text] [Related]
18. Glucose dependent miR-451a expression contributes to parathyroid hormone mediated osteoblast differentiation.
Karvande A; Kushwaha P; Ahmad N; Adhikary S; Kothari P; Tripathi AK; Khedgikar V; Trivedi R
Bone; 2018 Dec; 117():98-115. PubMed ID: 30218791
[TBL] [Abstract][Full Text] [Related]
19. Absence of bone sialoprotein (BSP) impairs primary bone formation and resorption: the marrow ablation model under PTH challenge.
Wade-Gueye NM; Boudiffa M; Vanden-Bossche A; Laroche N; Aubin JE; Vico L; Lafage-Proust MH; Malaval L
Bone; 2012 May; 50(5):1064-73. PubMed ID: 22586700
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor I suppresses parathyroid hormone (PTH)/PTH-related protein receptor expression via a mitogen-activated protein kinase pathway in UMR-106 osteoblast-like cells.
Kawane T; Horiuchi N
Endocrinology; 1999 Feb; 140(2):871-9. PubMed ID: 9927318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
